We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR (ECREST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02687386
Recruitment Status : Terminated (Study medication no longer in production)
First Posted : February 22, 2016
Last Update Posted : February 14, 2022
Engeneic Pty Limited
Information provided by (Responsible Party):
Dr David Ziegler, Sydney Children's Hospitals Network

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 29, 2021
Actual Study Completion Date : December 29, 2021